A life-extending prostate cancer drug is to be made available to thousands of men in England in a matter of weeks, after a ...

Around 55,000 new cases of prostate cancer are diagnosed in the UK every year, and super drug abiraterone will offer hope to ...

To help meet the potentially complex needs of patients after prostate cancer treatment and offer the precision and care ...

Cancer is still the most common cause of death for men in the US ages 60 to 79 and women ages 40 to 79. For all adults ...

Thousands of men with prostate cancer will be offered a life-extending drug on the NHS within weeks. For the first time patients whose prostate cancer has not spread will be able to receive the drug ...